Google looks to utilise AI to further overhaul the GP-patient relationship
It has recently been announced that Google is set to invest in a new research project, Medical Digital Assist, in order to further transform the GP-patient experience through voice recognition and touch technologies, CNBC reports.
Part of its Google AI division, the project will deliver a world-class Ai speech recognition system, and is collaborating with Stanford Medical to support electronic health records (EHRs)
"It is even more complicated than we originally thought," stated Dr Steven Lin, a Stanford physician heading the research with Google.
"If solved, it can potentially unshackle physicians from EHRs and bring providers back to the joys of medicine: actually interacting with patients."
- Looking past the hype: Getting real-world results from AI in healthcare
- Dive-by medicine
- The June edition for Healthcare Global is live!
Physicians are placing increased focus on inputting patient notes, rather than on the patient experience. Such technologies could switch such ratios and enhance the patient experience across the healthcare spectrum.
To this end, the company will be ramping up its recruitment and development efforts and is looking for a new medical assist project manager, who can bolster new business deals and be responsible for all commercial and legal concerns.
The news follows on from a recent blog outlining the tech giant’s plans to transform the input of data within EHR’s by utilising voice recognition technology and medical scribes to support GPs in their everyday roles.
“While most of the current solutions in medical domain focus on transcribing doctor dictations (i.e., single speaker speech consisting of predictable medical terminology), Google’s research shows that it is possible to build a model which can handle multiple speaker conversations covering everything from weather to complex medical diagnosis,” the company added.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”